Suggestions
Anne Moore
Business Strategy, M&A/Fundraising in Life Sciences
Professional Background
Dr. Anne Moore is a highly accomplished professional with an extensive background in healthcare, life sciences, and biotechnology management. Currently serving in strategy consulting at CEPTON Strategies, she leverages her deep understanding of the healthcare sector to help organizations navigate complex challenges and identify growth opportunities. With a wealth of experience in corporate strategy, investment banking, and scientific research, Dr. Moore has built a reputation as a trusted advisor and a strategic thinker within the biotechnology industry.
Dr. Moore previously held the prestigious role of Vice President of Corporate Strategy and was an ExCo member at Celyad, a biopharmaceutical company focused on developing innovative cellular therapies for cancer treatment. Here, she played a vital role in shaping the company’s strategic direction and advancing its portfolio of therapies, showcasing her ability to integrate scientific knowledge with business acumen. She has also been a part of notable investment banking firms, such as Bryan, Garnier & Co and Credit Suisse, where her focus was primarily on healthcare, allowing her to develop crucial insights into market dynamics and investment trends within life sciences.
Prior to her leadership roles in corporate strategy and finance, Dr. Moore honed her consulting skills with M.H.C. Consulting and Bionest Partners, where she provided strategic advice to various healthcare clients. Her journey began as a sales representative for B2B laboratory equipment at SCIENCETEC, and her role as a scientist at INSERM established her strong foundation in research and data analysis. This unique combination of experiences empowers her to approach challenges from multiple perspectives, making her a valuable asset in any strategic discussion.
Education and Achievements
Dr. Anne Moore's educational background is as impressive as her professional accomplishments. She pursued an MBA in Biotechnology Management from the renowned Toulouse Business School, where she gained critical insights into the intersection of business and biotechnology. This education equipped her with the strategic tools necessary to understand the complexities of managing biotech companies in a rapidly evolving market.
She further distinguished herself by obtaining a PhD in Life Sciences, specializing in Human Genetics and Pulmonary Diseases, from Université Paris-Est Créteil (UPEC). Her research in this area has contributed significantly to the scientific community, enriching her expertise and allowing her to translate complex scientific concepts into actionable business strategies.
Achievements
Throughout her illustrious career, Dr. Moore has achieved numerous milestones, demonstrating her leadership skills and domain expertise. Her strategic contributions as Vice President of Corporate Strategy at Celyad were pivotal in driving the company's focus on innovative therapies. With her extensive experience in both consulting and investment banking, she has played a significant role in advising clients on market entry strategies, due diligence, and corporate development initiatives.
Dr. Moore’s scientific background has not only informed her strategic decision-making but has also allowed her to contribute to community education and mentorship initiatives focused on science and healthcare careers. She is often invited to speak at industry conferences, sharing her insights and experiences in the healthcare sector, which continue to inspire the next generation of professionals in biotechnology and life sciences.
